A complete application in a minute
Tailored resume and cover letter, ready to send.
Iovance Biotherapeutics seeks a Senior Manager, U.S. Market Access Marketing to translate clinical and economic evidence into differentiated value messaging for AMTAGVI and pipeline therapies. Lead cross-functional partnerships to shape payer/provider strategies and resources.
This role drives market access strategy, payer materials, and field enablement across the U.S., with travel and regulatory considerations typical for biopharma access teams.
Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com. Amtagvi® and its accompanying design marks, Proleukin®, Iovance®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com.
In the U.S. Cell and Gene therapy (CGT) market, access decisions span Commercial and Government Health Plans as well as clinical, formulary, finance, and value-analysis stakeholders within Authorized Treatment Centers (ATCs), integrated delivery networks (IDNs), and other provider organizations. Iovance is seeking a Senior Manager, U.S. Market Access Marketing, to translate clinical and economic evidence into differentiated value messaging and resources for AMTAGVI and pipeline therapies.
This job operates in a professional or remote office environment and requires operating standard office equipment and keyboards.
The annual base salary we reasonably expect to pay is listed. Individual pay decisions depend on various factors, such as primary work location, complexity and responsibility of the role, job duties/requirements, and relevant education, experience and skills.
$140,000—$160,000 USD
The statements contained in this document are intended to describe the general nature and level of work being performed by a colleague assigned to this description. They are not intended to constitute a comprehensive list of functions, duties, or local variances. Management retains the discretion to add or to change the duties of the position at any time.
Iovance is committed to cultivating and offering a diverse and inclusive work environment. As an equal-opportunity employer, our employees and applicants will be considered without regard to an individual’s race, color, religion, sex, pregnancy, national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information, military and veteran status, and any other characteristic protected by applicable law.